Ladenburg Thalmann Financial Services’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $45K | Buy |
5,168
+3,497
| +209% | +$30.5K | ﹤0.01% | 3598 |
|
2019
Q3 | $18K | Buy |
1,671
+199
| +14% | +$2.14K | ﹤0.01% | 4108 |
|
2019
Q2 | $19K | Sell |
1,472
-697
| -32% | -$9K | ﹤0.01% | 4088 |
|
2019
Q1 | $85K | Buy |
2,169
+1,556
| +254% | +$61K | ﹤0.01% | 3004 |
|
2018
Q4 | $12K | Sell |
613
-78
| -11% | -$1.53K | ﹤0.01% | 4180 |
|
2018
Q3 | $32K | Sell |
691
-856
| -55% | -$39.6K | ﹤0.01% | 3612 |
|
2018
Q2 | $105K | Hold |
1,547
| – | – | ﹤0.01% | 2718 |
|
2018
Q1 | $105K | Buy |
1,547
+1,167
| +307% | +$79.2K | ﹤0.01% | 2718 |
|
2017
Q4 | $38K | Buy |
380
+6
| +2% | +$600 | ﹤0.01% | 3411 |
|
2017
Q3 | $45K | Hold |
374
| – | – | ﹤0.01% | 3154 |
|
2017
Q2 | $33K | Hold |
374
| – | – | ﹤0.01% | 3296 |
|
2017
Q1 | $14K | Hold |
374
| – | – | ﹤0.01% | 3779 |
|
2016
Q4 | $11K | Buy |
374
+300
| +405% | +$8.82K | ﹤0.01% | 3834 |
|
2016
Q3 | $5K | Hold |
74
| – | – | ﹤0.01% | 4167 |
|
2016
Q2 | $2K | Hold |
74
| – | – | ﹤0.01% | 4420 |
|
2016
Q1 | $2K | Sell |
74
-225
| -75% | -$6.08K | ﹤0.01% | 4398 |
|
2015
Q4 | $23K | Sell |
299
-410
| -58% | -$31.5K | ﹤0.01% | 3123 |
|
2015
Q3 | $54K | Buy |
709
+50
| +8% | +$3.81K | ﹤0.01% | 2410 |
|
2015
Q2 | $77K | Sell |
659
-49
| -7% | -$5.73K | ﹤0.01% | 2290 |
|
2015
Q1 | $167K | Buy |
708
+9
| +1% | +$2.12K | ﹤0.01% | 1707 |
|
2014
Q4 | $132K | Sell |
699
-257
| -27% | -$48.5K | ﹤0.01% | 1707 |
|
2014
Q3 | $228K | Buy |
956
+902
| +1,670% | +$215K | 0.01% | 1152 |
|
2014
Q2 | $4K | Buy |
54
+47
| +671% | +$3.48K | ﹤0.01% | 3460 |
|
2014
Q1 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 3641 |
|